Genetics can predict success of psychiatric medications

null
GeneSight Psychotropic Test
The enhancement of GeneSight Psychotropic test helps clinicians make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, post-traumatic stress disorder bipolar disorder, schizophrenia and other behavioral health disorders. GeneSight Psychotropic now covers 38 FDA-approved medications, including recently approved levomilnacipran (Fetzima®) and vortioxetine (Brintellix®). According to Bryan M. Dechairo, Ph.D., Senior Vice President, Medical Affairs & Clinical Development at Assurex Health, “GeneSight Psychotropic is now the only test to integrate scientifically validated drug response and metabolism genes, including CYP3A4, for a broad range of psychiatric medications into an easy-to-interpret report for clinicians to see which medications may be optimal for individual patients.”  To learn more about antidepressant and antipsychotic medication see here: http://www.examiner.com/article/genetics-can-predict-success-of-psychiatric-medications.

 

 

 

 

Advertisements
This entry was posted in Health Information and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s